GlassScriptPhysician profile
Jeffrey H Lin
NPI 1891704169
$2,751.24
in general payments reported to CMS, 2019-2025
18 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $99.07 · 2021: $180 · 2022: $1,259 · 2023: $485 · 2024: $208 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $1,153.46 | 2021-2022 | |
| Inspire Medical Systems, INC. | $354.07 | 2023-2024 | Inspire |
| Glaxosmithkline, LLC. | $254.96 | 2019-2024 | Nucala |
| Actelion Pharmaceuticals US, INC. | $166.07 | 2019-2023 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.33 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $134.96 | 2025 | |
| Insmed, INC. | $124.50 | 2022 | |
| Harmony Biosciences LLC | $123.74 | 2025 | |
| Cook Medical LLC | $80.76 | 2019-2025 | Cook |
| Astrazeneca Pharmaceuticals LP | $67.92 | 2019-2020 | |
| Resmed Corp | $28.09 | 2022 | |
| Medtronic Vascular, INC. | $23.45 | 2019 | |
| Paratek Pharmaceuticals, INC. | $23.14 | 2019 | |
| Philips North America LLC | $18.74 | 2019 | |
| Mylan Specialty L.P. | $17.57 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $13.60 | 2019 | |
| Merck Sharp & Dohme LLC | $13.26 | 2019 | |
| Genentech USA, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.